Shares of Sotera Health Company (SHC) surged 7.48% in Thursday's trading session following the release of better-than-expected first-quarter 2025 results. The healthcare services provider reported revenue of $254.5 million, up 2.6% year-over-year and beating analyst estimates of $245.8 million. On a constant currency basis, revenue growth was even stronger at 4.4%.
The company's adjusted earnings per share came in at $0.14, surpassing the consensus estimate of $0.12. Adjusted EBITDA showed impressive growth, increasing 8.8% to $122 million, or 11.2% on a constant currency basis. Sotera Health's Chairman and CEO, Michael B. Petras, Jr., expressed satisfaction with the company's "solid start to the year" and highlighted the strong double-digit Adjusted EBITDA growth.
Adding to investor optimism, Sotera Health reaffirmed its full-year 2025 outlook, projecting net revenue growth of 4.0% to 6.0% and Adjusted EBITDA growth of 4.5% to 6.5% on a constant currency basis. The company's ability to maintain its guidance despite economic uncertainties likely contributed to the positive market reaction, driving the stock's significant intraday gain.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.